https://sputnikglobe.com/20210219/san-marino-becomes-30th-country-to-register-russias-sputnik-v-vaccine-rdif-confirms-1082127232.html
San Marino Becomes 30th Country to Register Russia's Sputnik V Vaccine, RDIF Confirms
San Marino Becomes 30th Country to Register Russia's Sputnik V Vaccine, RDIF Confirms
Sputnik International
MOSCOW, (Sputnik) - San Marino has become the 30th country to register Russia's coronavirus vaccine Sputnik V, the Russian Direct Investment Fund (RDIF) said... 19.02.2021, Sputnik International
2021-02-19T11:19+0000
2021-02-19T11:19+0000
2021-02-19T11:34+0000
https://cdn1.img.sputnikglobe.com/img/07e4/08/0b/1080134831_0:203:3072:1939_1920x0_80_0_0_98c92a0e3e063a08842e2b1d3c778f18.jpg
russia
san marino
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2021
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
https://cdn1.img.sputnikglobe.com/img/07e4/08/0b/1080134831_0:106:3072:2036_1920x0_80_0_0_e7ff3a0c95b6a6872781ecd0e4a30d59.jpgSputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
newsfeed, europe, russia, san marino, russian direct investment fund (rdif)
newsfeed, europe, russia, san marino, russian direct investment fund (rdif)
San Marino Becomes 30th Country to Register Russia's Sputnik V Vaccine, RDIF Confirms
11:19 GMT 19.02.2021 (Updated: 11:34 GMT 19.02.2021) MOSCOW, (Sputnik) - San Marino has become the 30th country to register Russia's coronavirus vaccine Sputnik V, the Russian Direct Investment Fund (RDIF) said Friday.
"The vaccine was approved under the emergency use authorisation procedure. San Marino has become the 30th country in the world to approve Sputnik V", the fund said in a statement.
Developed by the Gamaleya Research Institute of Epidemiology and Microbiology, Sputnik V was the world's first officially-registered vaccine against COVID-19. According to The Lancet, the medication has been proven to be 91.6 percent efficient against COVID-19.